Answers are grounded in this paper and cite their sources.
Background This study revealed a correlation between the partial pressure of carbon dioxide (PCO 2 ) and mortality rates among adult patients with acute respiratory distress syndrome, heart failure, and cardiac arrest. However, the relationship between PCO 2 and outcomes in critically ill neonates admitted to intensive care units (ICU) remains unclear. Our objective was to explore the association between PCO 2 and all-cause in-hospital mortality among critically ill neonates. Methods This research included a total of 1694 patients from the Pediatric Intensive Care (PIC) database. The primary focus was on 90-day mortality due to any cause among neonates in critical condition, while the secondary endpoint was the duration of their hospital or ICU stay. Smooth curve fitting and Cox proportional hazards regression models were employed to explore the associations between PCO 2 and overall mortality. Kaplan‒Meier curves were used to assess survival differences between groups, followed by subgroup analysis and interaction tests. Results Smooth curve fitting revealed a linear correlation between PCO 2 levels and 90-day mortality due to any cause among critically ill neonates. The analysis revealed that PCO 2 was associated with all-cause mortality in these neonates (HR = 1.028, 95% CI: 1.011, 1.046). Neonates with a PCO 2 <35 mmHg exhibited a 32.2% reduced risk of mortality compared to those with PCO 2 of 35–55 mmHg (HR = 0.678, 95% CI: 0.359, 1.282), although this difference was not statistically significant. Conversely, neonates with a PCO 2 >55 mmHg had a 107.0% increased risk of mortality compared with those with a PCO 2 of 35–55 mmHg (HR = 2.070; 95% CI: 1.096, 3.910). Additionally, both neonates with PCO 2 <35 mmHg and those with PCO 2 >55 mmHg had longer lengths of stay in the hospital and ICU than did those with PCO 2 ranging from 35 to 55 mmHg. Conclusion Higher levels of PCO 2 are associated with 90-day in-hospital all-cause mortality among critically ill neonates. Clinical trial number Not applicable.
No takes yet. Share an insight, caveat, or question.
Peng et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: